Residual inflammation in the cerebrospinal fluid after short- and long-term natalizumab treatment in relapsing-remitting multiple sclerosis. - Buhelt S; Hansen MB; Søndergaard HB; El Mahdaoui S; Hansen MM; Mahler MR; Romme Christensen J; Sellebjerg F (Frontiers in immunology, 2026)